_id
6919e7223c536f8df23181d0
Ticker
DXRX.LSE
Name
Diaceutics PLC
Exchange
LSE
Address
Building Two, Belfast, United Kingdom, BT9 6GW
Country
UK
Sector
Healthcare
Industry
Health Information Services
Currency
GBX
Website
https://www.diaceutics.com
Description
Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data from a network of laboratories. It also provides DXRX data solutions, including DXRX Signal, which delivers an actionable alert of a testing behavior for making treatment decisions; DXRX Physician Mapping that examines physician testing behavior using patient level data to determine testing rates, methodology, and physician to lab relationship; DXRX Lab Mapping that offers insights into labs currently testing patients diagnosed with a specific disease or biomarker; and DXRX Disease Testing Rate Tracker, which delivers biomarker testing rate reports. In addition, the company offers professional services, such as market landscape, implementation, and consulting services. It operates in North America, the United Kingdom, Europe, Asia, and internationally. The company was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.
Last Close
1285000
Volume
13585
Current Price
139
Change
-1.556420233463035
Last Updated
2025-12-30T10:49:35.007Z
Image
https://logo.clearbit.com/www.diaceutics.com
Ipo Date
-
Market Cap
108742616
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4.2
Strong Buy
1
Buy
4
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
14564000
Cost Of Revenue
2477000
Gross Profit
12087000
Operating Expenses
15266000
Operating Income
-3348000
Interest Expense
29000
Pretax Income
-3053000
Net Income
-2401000
Eps
-0.028400191654571152
Dividends Per Share
-
Shares Outstanding
84624602
Income Tax Expense
-652000
EBITDA
-1341000
Operating Margin
-22.988190057676462
Total Other Income Expense Net
295000
Cash
10384000
Short Term Investments
-
Receivables
11366000
Inventories
-
Total Current Assets
24464000
Property Plant Equipment
1711000
Total Assets
44423000
Payables
1073000
Short Term Debt
458000
Long Term Debt
-
Total Liabilities
7182000
Equity
37241000
Bs_currency_symbol
GBP
Depreciation
2701000
Change In Working Capital
3863000
Cash From Operations
800000
Capital Expenditures
55000
Cash From Investing
-2822000
Cash From Financing
-141000
Net Change In Cash
-2360000
Cf_currency_symbol
-
PE
-
PB
315.54721777073655
ROE
-6.4471952955076395
ROA
-5.404857843909686
FCF
745000
Fcf Percent
0.051153529250205984
Piotroski FScore
2
Health Score
31
Deep Value Investing Score
5
Defensive Investing Score
7
Dividend Investing Score
3
Economic Moat Investing Score
6.3
Garp Investing Score
4
Growth Investing Score
3
Momentum Investing Score
3
Net Net Investing Score
4
Quality Investing Score
4.5
Value Investing Score
3.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
14564000
Quarters > 0 > income Statement > cost Of Revenue
2477000
Quarters > 0 > income Statement > gross Profit
12087000
Quarters > 0 > income Statement > operating Expenses
15266000
Quarters > 0 > income Statement > operating Income
-3348000
Quarters > 0 > income Statement > interest Expense
29000
Quarters > 0 > income Statement > pretax Income
-3053000
Quarters > 0 > income Statement > net Income
-2401000
Quarters > 0 > income Statement > eps
-0.028400191654571152
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
84541683
Quarters > 0 > income Statement > income Tax Expense
-652000
Quarters > 0 > income Statement > EBITDA
-1341000
Quarters > 0 > income Statement > operating Margin
-22.988190057676462
Quarters > 0 > income Statement > total Other Income Expense Net
295000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
10384000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
11366000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
24464000
Quarters > 0 > balance Sheet > property Plant Equipment
1711000
Quarters > 0 > balance Sheet > total Assets
44423000
Quarters > 0 > balance Sheet > payables
1073000
Quarters > 0 > balance Sheet > short Term Debt
458000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
7182000
Quarters > 0 > balance Sheet > equity
37241000
Quarters > 0 > balance Sheet > currency_symbol
GBP
Quarters > 0 > cash Flow > net Income
-2401000
Quarters > 0 > cash Flow > depreciation
2701000
Quarters > 0 > cash Flow > change In Working Capital
3863000
Quarters > 0 > cash Flow > cash From Operations
800000
Quarters > 0 > cash Flow > capital Expenditures
55000
Quarters > 0 > cash Flow > cash From Investing
-2822000
Quarters > 0 > cash Flow > cash From Financing
-141000
Quarters > 0 > cash Flow > net Change In Cash
-2360000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.028400191654571152
Quarters > 0 > ratios > PB
315.54721777073655
Quarters > 0 > ratios > ROE
-6.4471952955076395
Quarters > 0 > ratios > ROA
-5.404857843909686
Quarters > 0 > ratios > FCF
745000
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
0.051153529250205984
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
19838000
Quarters > 1 > income Statement > cost Of Revenue
2299000
Quarters > 1 > income Statement > gross Profit
17539000
Quarters > 1 > income Statement > operating Expenses
16409000
Quarters > 1 > income Statement > operating Income
1130000
Quarters > 1 > income Statement > interest Expense
26000
Quarters > 1 > income Statement > pretax Income
1356000
Quarters > 1 > income Statement > net Income
881000
Quarters > 1 > income Statement > eps
0.010431491234599076
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
84455806
Quarters > 1 > income Statement > income Tax Expense
475000
Quarters > 1 > income Statement > EBITDA
4035000
Quarters > 1 > income Statement > operating Margin
5.69613872366166
Quarters > 1 > income Statement > total Other Income Expense Net
226000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
12744000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
14961000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
29529000
Quarters > 1 > balance Sheet > property Plant Equipment
1678000
Quarters > 1 > balance Sheet > total Assets
48620000
Quarters > 1 > balance Sheet > payables
1217000
Quarters > 1 > balance Sheet > short Term Debt
306000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
8763000
Quarters > 1 > balance Sheet > equity
39857000
Quarters > 1 > balance Sheet > currency_symbol
GBP
Quarters > 1 > cash Flow > net Income
881000
Quarters > 1 > cash Flow > depreciation
2352000
Quarters > 1 > cash Flow > change In Working Capital
-6292000
Quarters > 1 > cash Flow > cash From Operations
-501000
Quarters > 1 > cash Flow > capital Expenditures
39000
Quarters > 1 > cash Flow > cash From Investing
-2934000
Quarters > 1 > cash Flow > cash From Financing
-101000
Quarters > 1 > cash Flow > net Change In Cash
-4004999
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
0.010431491234599076
Quarters > 1 > ratios > PB
294.5368952505206
Quarters > 1 > ratios > ROE
2.2104021878214617
Quarters > 1 > ratios > ROA
1.8120115178938707
Quarters > 1 > ratios > FCF
-540000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-0.027220485936082266
Quarters > 1 > health Score
45
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
12320000
Quarters > 2 > income Statement > cost Of Revenue
3707000
Quarters > 2 > income Statement > gross Profit
8613000
Quarters > 2 > income Statement > operating Expenses
12206000
Quarters > 2 > income Statement > operating Income
-3593000
Quarters > 2 > income Statement > interest Expense
28000
Quarters > 2 > income Statement > pretax Income
-3264000
Quarters > 2 > income Statement > net Income
-2584000
Quarters > 2 > income Statement > eps
-0.030597534804932665
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
84451248
Quarters > 2 > income Statement > income Tax Expense
-680000
Quarters > 2 > income Statement > EBITDA
-961000
Quarters > 2 > income Statement > operating Margin
-29.16396103896104
Quarters > 2 > income Statement > total Other Income Expense Net
329000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
16749000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
9684000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
27229000
Quarters > 2 > balance Sheet > property Plant Equipment
1803000
Quarters > 2 > balance Sheet > total Assets
45426000
Quarters > 2 > balance Sheet > payables
610000
Quarters > 2 > balance Sheet > short Term Debt
300000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
6686000
Quarters > 2 > balance Sheet > equity
38740000
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
-2584000
Quarters > 2 > cash Flow > depreciation
2275000
Quarters > 2 > cash Flow > change In Working Capital
2842000
Quarters > 2 > cash Flow > cash From Operations
1501000
Quarters > 2 > cash Flow > capital Expenditures
61000
Quarters > 2 > cash Flow > cash From Investing
-1446000
Quarters > 2 > cash Flow > cash From Financing
37000
Quarters > 2 > cash Flow > net Change In Cash
81999
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.030597534804932665
Quarters > 2 > ratios > PB
303.01299617965924
Quarters > 2 > ratios > ROE
-6.670108415074857
Quarters > 2 > ratios > ROA
-5.688372297803021
Quarters > 2 > ratios > FCF
1440000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
0.11688311688311688
Quarters > 2 > health Score
37
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
13775000
Quarters > 3 > income Statement > cost Of Revenue
2769000
Quarters > 3 > income Statement > gross Profit
11006000
Quarters > 3 > income Statement > operating Expenses
11858000
Quarters > 3 > income Statement > operating Income
-845000
Quarters > 3 > income Statement > interest Expense
24000
Quarters > 3 > income Statement > pretax Income
-483000
Quarters > 3 > income Statement > net Income
-261000
Quarters > 3 > income Statement > eps
-0.0030987711579583046
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
84226936
Quarters > 3 > income Statement > income Tax Expense
-222000
Quarters > 3 > income Statement > EBITDA
2339000
Quarters > 3 > income Statement > operating Margin
-6.1343012704174225
Quarters > 3 > income Statement > total Other Income Expense Net
362000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
16667000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
10126000
Quarters > 3 > balance Sheet > inventories
1
Quarters > 3 > balance Sheet > total Current Assets
28040000
Quarters > 3 > balance Sheet > property Plant Equipment
1899000
Quarters > 3 > balance Sheet > total Assets
46344000
Quarters > 3 > balance Sheet > payables
1065000
Quarters > 3 > balance Sheet > short Term Debt
292000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
5558000
Quarters > 3 > balance Sheet > equity
40786000
Quarters > 3 > balance Sheet > currency_symbol
GBP
Quarters > 3 > cash Flow > net Income
-261000
Quarters > 3 > cash Flow > depreciation
2147000
Quarters > 3 > cash Flow > change In Working Capital
-1320000
Quarters > 3 > cash Flow > cash From Operations
613000
Quarters > 3 > cash Flow > capital Expenditures
64000
Quarters > 3 > cash Flow > cash From Investing
-1516000
Quarters > 3 > cash Flow > cash From Financing
-98000
Quarters > 3 > cash Flow > net Change In Cash
-1213000
Quarters > 3 > cash Flow > currency_symbol
GBP
Quarters > 3 > ratios > PE
-0.0030987711579583046
Quarters > 3 > ratios > PB
287.04810729171777
Quarters > 3 > ratios > ROE
-0.6399254646202128
Quarters > 3 > ratios > ROA
-0.5631796996374936
Quarters > 3 > ratios > FCF
549000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
0.03985480943738657
Quarters > 3 > health Score
30
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
32158000
Annuals > 0 > income Statement > cost Of Revenue
3888000
Annuals > 0 > income Statement > gross Profit
28270000
Annuals > 0 > income Statement > operating Expenses
30725000
Annuals > 0 > income Statement > operating Income
-2455000
Annuals > 0 > income Statement > interest Expense
54000
Annuals > 0 > income Statement > pretax Income
-1908000
Annuals > 0 > income Statement > net Income
-1703000
Annuals > 0 > income Statement > eps
-0.020164936391584926
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
84453527
Annuals > 0 > income Statement > income Tax Expense
-205000
Annuals > 0 > income Statement > EBITDA
2773000
Annuals > 0 > income Statement > operating Margin
-7.634181230176005
Annuals > 0 > income Statement > total Other Income Expense Net
547000
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
12744000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
14961000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
29529000
Annuals > 0 > balance Sheet > property Plant Equipment
1678000
Annuals > 0 > balance Sheet > total Assets
48620000
Annuals > 0 > balance Sheet > payables
1217000
Annuals > 0 > balance Sheet > short Term Debt
153000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
8763000
Annuals > 0 > balance Sheet > equity
39857000
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
-1908000
Annuals > 0 > cash Flow > depreciation
4627000
Annuals > 0 > cash Flow > change In Working Capital
-1302000
Annuals > 0 > cash Flow > cash From Operations
651000
Annuals > 0 > cash Flow > capital Expenditures
4632000
Annuals > 0 > cash Flow > cash From Investing
-4031000
Annuals > 0 > cash Flow > cash From Financing
-64000
Annuals > 0 > cash Flow > net Change In Cash
-3923000
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
-0.020164936391584926
Annuals > 0 > ratios > PB
265.7382129836039
Annuals > 0 > ratios > ROE
-4.272775171237173
Annuals > 0 > ratios > ROA
-3.5026737967914436
Annuals > 0 > ratios > FCF
-3981000
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
-0.12379501212761988
Annuals > 0 > health Score
28
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
23699000
Annuals > 1 > income Statement > cost Of Revenue
3993000
Annuals > 1 > income Statement > gross Profit
19706000
Annuals > 1 > income Statement > operating Expenses
22724000
Annuals > 1 > income Statement > operating Income
-3018000
Annuals > 1 > income Statement > interest Expense
66000
Annuals > 1 > income Statement > pretax Income
-2438000
Annuals > 1 > income Statement > net Income
-1746000
Annuals > 1 > income Statement > eps
-0.020729739300732703
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
84226819
Annuals > 1 > income Statement > income Tax Expense
-692000
Annuals > 1 > income Statement > EBITDA
2359000
Annuals > 1 > income Statement > operating Margin
-12.734714544917509
Annuals > 1 > income Statement > total Other Income Expense Net
580000
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
16667000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
10126000
Annuals > 1 > balance Sheet > inventories
1
Annuals > 1 > balance Sheet > total Current Assets
28040000
Annuals > 1 > balance Sheet > property Plant Equipment
1899000
Annuals > 1 > balance Sheet > total Assets
46344000
Annuals > 1 > balance Sheet > payables
1065000
Annuals > 1 > balance Sheet > short Term Debt
146000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
5558000
Annuals > 1 > balance Sheet > equity
40786000
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
-1746000
Annuals > 1 > cash Flow > depreciation
4773000
Annuals > 1 > cash Flow > change In Working Capital
-1540000
Annuals > 1 > cash Flow > cash From Operations
1311000
Annuals > 1 > cash Flow > capital Expenditures
4855000
Annuals > 1 > cash Flow > cash From Investing
-4209000
Annuals > 1 > cash Flow > cash From Financing
-239000
Annuals > 1 > cash Flow > net Change In Cash
-3174000
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
-0.020729739300732703
Annuals > 1 > ratios > PB
258.98827876814346
Annuals > 1 > ratios > ROE
-4.280880694355906
Annuals > 1 > ratios > ROA
-3.767477990678405
Annuals > 1 > ratios > FCF
-3544000
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
-0.14954217477530699
Annuals > 1 > health Score
28
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
19504000
Annuals > 2 > income Statement > cost Of Revenue
5467000
Annuals > 2 > income Statement > gross Profit
14037000
Annuals > 2 > income Statement > operating Expenses
13706000
Annuals > 2 > income Statement > operating Income
575000
Annuals > 2 > income Statement > interest Expense
122000
Annuals > 2 > income Statement > pretax Income
564000
Annuals > 2 > income Statement > net Income
724000
Annuals > 2 > income Statement > eps
0.008409850485751918
Annuals > 2 > income Statement > dividends Per Share
191000
Annuals > 2 > income Statement > shares Outstanding
86089521
Annuals > 2 > income Statement > income Tax Expense
-160000
Annuals > 2 > income Statement > EBITDA
3608000
Annuals > 2 > income Statement > operating Margin
2.94811320754717
Annuals > 2 > income Statement > total Other Income Expense Net
-11000
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
19841000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
10427000
Annuals > 2 > balance Sheet > inventories
1
Annuals > 2 > balance Sheet > total Current Assets
30896000
Annuals > 2 > balance Sheet > property Plant Equipment
2092000
Annuals > 2 > balance Sheet > total Assets
48256000
Annuals > 2 > balance Sheet > payables
759000
Annuals > 2 > balance Sheet > short Term Debt
248000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
5742000
Annuals > 2 > balance Sheet > equity
42514000
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
724000
Annuals > 2 > cash Flow > depreciation
3008000
Annuals > 2 > cash Flow > change In Working Capital
-328000
Annuals > 2 > cash Flow > cash From Operations
5096000
Annuals > 2 > cash Flow > capital Expenditures
4870000
Annuals > 2 > cash Flow > cash From Investing
-4870000
Annuals > 2 > cash Flow > cash From Financing
-132000
Annuals > 2 > cash Flow > net Change In Cash
166000
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
0.008409850485751918
Annuals > 2 > ratios > PB
253.95639206878909
Annuals > 2 > ratios > ROE
1.7029684339276474
Annuals > 2 > ratios > ROA
1.5003315649867373
Annuals > 2 > ratios > FCF
226000
Annuals > 2 > ratios > Piotroski FScore
3
Annuals > 2 > ratios > fcf Percent
0.011587366694011485
Annuals > 2 > health Score
44
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
13943000
Annuals > 3 > income Statement > cost Of Revenue
3377000
Annuals > 3 > income Statement > gross Profit
10566000
Annuals > 3 > income Statement > operating Expenses
10253000
Annuals > 3 > income Statement > operating Income
550000
Annuals > 3 > income Statement > interest Expense
88000
Annuals > 3 > income Statement > pretax Income
462000
Annuals > 3 > income Statement > net Income
561000
Annuals > 3 > income Statement > eps
0.006604494552793015
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
84942155
Annuals > 3 > income Statement > income Tax Expense
-99000
Annuals > 3 > income Statement > EBITDA
2349000
Annuals > 3 > income Statement > operating Margin
3.9446317148389873
Annuals > 3 > income Statement > total Other Income Expense Net
-88000
Annuals > 3 > income Statement > currency_symbol
GBP
Annuals > 3 > balance Sheet > cash
19675000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
9957000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
30062000
Annuals > 3 > balance Sheet > property Plant Equipment
2129000
Annuals > 3 > balance Sheet > total Assets
45013000
Annuals > 3 > balance Sheet > payables
513000
Annuals > 3 > balance Sheet > short Term Debt
276000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
4364000
Annuals > 3 > balance Sheet > equity
40649000
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
561000
Annuals > 3 > cash Flow > depreciation
1799000
Annuals > 3 > cash Flow > change In Working Capital
-1658000
Annuals > 3 > cash Flow > cash From Operations
570000
Annuals > 3 > cash Flow > capital Expenditures
5601000
Annuals > 3 > cash Flow > cash From Investing
-5601000
Annuals > 3 > cash Flow > cash From Financing
-270000
Annuals > 3 > cash Flow > net Change In Cash
-5580000
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
0.006604494552793015
Annuals > 3 > ratios > PB
262.0681447006691
Annuals > 3 > ratios > ROE
1.3801077517282097
Annuals > 3 > ratios > ROA
1.2463066225312687
Annuals > 3 > ratios > FCF
-5031000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
-0.3608262210428172
Annuals > 3 > health Score
46
Valuation > metrics > PE
-0.028400191654571152
Valuation > metrics > PB
315.54721777073655
Valuation > final Score
20
Valuation > verdict
10418.2% Overvalued
Profitability > metrics > ROE
-6.4471952955076395
Profitability > metrics > ROA
-9.814421190320472
Profitability > metrics > Net Margin
-0.16485855534193902
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.19285196423296905
Risk > metrics > Interest Coverage
-115.44827586206897
Risk > final Score
-402
Risk > verdict
High
Liquidity > metrics > Current Ratio
15.979098628347485
Liquidity > metrics > Quick Ratio
15.979098628347485
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
40
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
20
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
100
Prev Risks > 1
-453
Prev Risks > 2
-81
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:01:08.052Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-05-11
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-12-31
Earnings History > 1 > report Date
2026-03-24
Earnings History > 1 > date
2025-12-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
0.0441
Earnings History > 1 > eps Difference
-0.0441
Earnings History > 1 > surprise Percent
-100
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-09-15
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.0284
Earnings History > 2 > eps Estimate
-0.0232
Earnings History > 2 > eps Difference
-0.0052
Earnings History > 2 > surprise Percent
-22.4138
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-21
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0.01
Earnings History > 3 > eps Estimate
0.0156
Earnings History > 3 > eps Difference
-0.0056
Earnings History > 3 > surprise Percent
-35.8974
Earnings History > 4 > period
2022-12-31
Earnings History > 4 > report Date
2023-03-20
Earnings History > 4 > date
2022-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
GBP
Earnings History > 4 > eps Actual
0.02
Earnings History > 4 > eps Estimate
1.43
Earnings History > 4 > eps Difference
-1.41
Earnings History > 4 > surprise Percent
-98.6014
Earnings History > 5 > period
2022-06-30
Earnings History > 5 > report Date
2022-09-28
Earnings History > 5 > date
2022-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
GBP
Earnings History > 5 > eps Actual
-0.01
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2021-12-31
Earnings History > 6 > report Date
2022-03-16
Earnings History > 6 > date
2021-12-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
GBP
Earnings History > 6 > eps Actual
0.01
Earnings History > 6 > eps Estimate
1.31
Earnings History > 6 > eps Difference
-1.3
Earnings History > 6 > surprise Percent
-99.2366
Earnings History > 7 > period
2021-06-30
Earnings History > 7 > report Date
2021-09-15
Earnings History > 7 > date
2021-06-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
GBP
Earnings History > 7 > eps Actual
0
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2020-12-31
Earnings History > 8 > report Date
2021-03-15
Earnings History > 8 > date
2020-12-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
GBP
Earnings History > 8 > eps Actual
-0.01
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.01
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2020-06-30
Earnings History > 9 > report Date
2020-09-07
Earnings History > 9 > date
2020-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
GBP
Earnings History > 9 > eps Actual
0.02
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2020-03-31
Earnings History > 10 > report Date
2020-04-27
Earnings History > 10 > date
2020-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
GBP
Earnings History > 10 > eps Actual
0.03
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
0.03
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2019-06-30
Earnings History > 11 > report Date
2019-09-09
Earnings History > 11 > date
2019-06-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
GBP
Earnings History > 11 > eps Actual
-0.03
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.03
Earnings History > 11 > surprise Percent
-
Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data from a network of laboratories. It also provides DXRX data solutions, including DXRX Signal, which delivers an actionable alert of a testing behavior for making treatment decisions; DXRX Physician Mapping that examines physician testing behavior using patient level data to determine testing rates, methodology, and physician to lab relationship; DXRX Lab Mapping that offers insights into labs currently testing patients diagnosed with a specific disease or biomarker; and DXRX Disease Testing Rate Tracker, which delivers biomarker testing rate reports. In addition, the company offers professional services, such as market landscape, implementation, and consulting services. It operates in North America, the United Kingdom, Europe, Asia, and internationally. The company was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.
Stock Price
GBp 0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AFTSE AIM All-Share Context Frames Diaceutics in Healthcare Data Services Kalkine Media
Read more →3 UK Penny Stocks With Market Caps Over £100M To Consider simplywall.st
Read more →Showing 2 of 7
(Last Updated 2025-06-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
1
Buy
4
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Diaceutics PLC
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
0.0441
Date
2025-06-30
EPS Actual
-0.0284
EPS Estimate
-0.0232
EPS Difference
-0.0052
Surprise Percent
-22.4138%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.